These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The scintigraphy of somatostatin receptors in the carcinoid tumor]. Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324 [TBL] [Abstract][Full Text] [Related]
8. In-111 octreotide imaging in staging of small cell lung cancer. Hochstenbag MM; Heidendal GA; Wouters EF; ten Velde GP Clin Nucl Med; 1997 Dec; 22(12):811-6. PubMed ID: 9408640 [TBL] [Abstract][Full Text] [Related]
9. 111In-octreotide scintigraphy in small cell lung cancer. Semprebene A; Ferraironi A; Franciotti G; Venturo I; Giunta S; Lopez M; Maini CL Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):108-10. PubMed ID: 9002764 [TBL] [Abstract][Full Text] [Related]
10. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. Baudin E; Lumbroso J; Schlumberger M; Leclere J; Giammarile F; Gardet P; Roche A; Travagli JP; Parmentier C J Nucl Med; 1996 Jun; 37(6):912-6. PubMed ID: 8683310 [TBL] [Abstract][Full Text] [Related]
11. The role of iodine-123-Tyr-3-octreotide scintigraphy in the staging of small-cell lung cancer. Leitha T; Meghdadi S; Studnicka M; Wolzt M; Marosi C; Angelberger P; Neumann M; Schlick W; Kletter K; Dudczak R J Nucl Med; 1993 Sep; 34(9):1397-402. PubMed ID: 8394882 [TBL] [Abstract][Full Text] [Related]
12. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors. Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873 [TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptor scintigraphy in the staging of small cell lung cancer. Bohuslavizki KH; Brenner W; Günther M; Eberhardt JU; Jahn N; Tinnemeyer S; Wolf H; Sippel C; Clausen M; Gatzemeier U; Henze E Nucl Med Commun; 1996 Mar; 17(3):191-6. PubMed ID: 8692484 [TBL] [Abstract][Full Text] [Related]
16. Clinical diagnostic application of 111In-DTPA-octreotide scintigraphy in small cell lung cancer. Vaccarili M; Lococo A; Fabiani F; Staffilano A Tumori; 2000; 86(3):224-8. PubMed ID: 10939603 [TBL] [Abstract][Full Text] [Related]
17. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. Lebtahi R; Cadiot G; Delahaye N; Genin R; Daou D; Peker MC; Chosidow D; Faraggi M; Mignon M; Le Guludec D J Nucl Med; 1999 Oct; 40(10):1602-8. PubMed ID: 10520698 [TBL] [Abstract][Full Text] [Related]
18. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy. Lastoria S; Vergara E; Palmieri G; Acampa W; Varrella P; Caracò C; Bianco RA; Muto P; Salvatore M J Nucl Med; 1998 Apr; 39(4):634-9. PubMed ID: 9544670 [TBL] [Abstract][Full Text] [Related]
19. Indium-111-DTPA-octreotide scintigraphy modulation by treatment with unlabelled somatostatin analogue in small-cell lung cancer. Soresi E; Bombardieri E; Chiti A; Boffi R; Invernizzi G; Crippa F; Maffioli L Tumori; 1995; 81(2):125-7. PubMed ID: 7778214 [TBL] [Abstract][Full Text] [Related]
20. [Bronchial carcinoid tumor and scintigraphy of somatostatin receptors: detection of bone metastasis]. Banzo J; Abós MD; Prats E; García F; Freile E; Razola P; Escalera T Rev Esp Med Nucl; 2001 Oct; 20(6):431-8. PubMed ID: 11578577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]